Stay updated with breaking news from Markwin Velders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Patient data from higher dose cNeT as monotherapy and cNeT in combination with checkpoint inhibitor expected in 2H 2022 - - Strong cash position of $266 million supports clinical development and
Investegate announcements from Syncona Limited, Achilles reports Full Year 2021 Results
Investegate announcements from Syncona Limited, Achilles reports Second Quarter 2021 Results
Investegate announcements from Achilles Therapeutics PLC, Achilles Therapeutics Reports Second Quarter 2021 Financial Results and Recent Business Highlights
- Presentations of translational science data at AACR and ASCO illustrate crucial path to potency assay - - Data from ten patients across CHIRON and THETIS studies anticipated in the fourth quarter